Table 3.
Multivariable models for associations between cancer treatment, chronic conditions and cognitive and HRQOL outcome
| Verbal reasoning | Word reading | Mathematics | Sustained attention |
Long-term verbal memory |
Verbal fluency | HRQOL General health |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Est. | P-val | Est. | P-val | Est. | P-val | Est. | P-val | Est. | P-val | Est. | P-val | Est. | P-val | ||
| Ridge regression |
Dactinomycin | 0.001 | 0.91 | 0.010 | 0.056 | 0.018 | 0.086 | 0.013 | 0.36 | 0.072 | 0.014 | 0.004 | 0.77 | 0.058 | 0.62 |
| Vincristine | −0.0001 | 0.95 | 0.0003 | 0.75 | −0.001 | 0.65 | −0.001 | 0.78 | −0.010 | 0.20 | 0.001 | 0.81 | 0.007 | 0.62 | |
| Doxorubicin | −0.0002 | 0.54 | −0.0003 | 0.15 | −0.001 | 0.12 | −0.0002 | 0.76 | −0.002 | 0.11 | −0.0004 | 0.49 | −0.0003 | 0.74 | |
| Radiation | |||||||||||||||
| Radiation to abdomen | 0.090 | 0.28 | −0.019 | 0.66 | 0.14 | 0.097 | −0.13 | 0.28 | 0.55 | 0.0062 | 0.12 | 0.30 | −0.16 | 0.45 | |
| Radiation to abdomen and chest | 0.021 | 0.84 | 0.028 | 0.62 | 0.019 | 0.86 | 0.20 | 0.21 | 0.46 | 0.070 | 0.40 | 0.0073 | −0.73 | 0.004 | |
|
Chronic conditions
Grade 2–4 |
|||||||||||||||
| Generalized linear models |
Cardiovascular system | 0.076 | 0.70 | 0.13 | 0.19 | 0.014 | 0.93 | 0.32 | 0.19 | 0.012 | 0.96 | −0.10 | 0.59 | −0.34 | 0.081 |
| Respiratory system | 0.080 | 0.67 | 0.054 | 0.59 | 0.022 | 0.89 | 0.18 | 0.45 | 0.23 | 0.30 | 0.20 | 0.28 | −0.23 | 0.22 | |
| Reproductive system | −0.13 | 0.52 | −0.041 | 0.70 | 0.123 | 0.47 | 0.15 | 0.56 | −0.051 | 0.83 | −0.17 | 0.39 | −0.46 | 0.021 | |
| Endocrine system | −0.34 | 0.053 | −0.11 | 0.25 | −0.26 | 0.084 | 0.15 | 0.52 | −0.23 | 0.27 | −0.15 | 0.39 | −0.44 | 0.012 | |
| Renal system | 0.45 | 0.11 | 0.023 | 0.88 | 0.25 | 0.29 | −0.23 | 0.51 | 0.28 | 0.40 | 0.25 | 0.37 | −0.66 | 0.016 | |
| Musculoskeletal system | 0.12 | 0.54 | −0.015 | 0.88 | 0.044 | 0.78 | −0.56 | 0.016 | 0.083 | 0.70 | −0.061 | 0.74 | −0.21 | 0.25 | |
| Neurology system | −0.44 | 0.052 | −0.18 | 0.15 | −0.30 | 0.11 | −0.73 | 0.010 | −0.78 | 0.0025 | −0.27 | 0.22 | −0.80 | <0.001 | |
| Second neoplasms (Yes) | 0.49 | 0.10 | 0.24 | 0.13 | 0.25 | 0.33 | 0.41 | 0.29 | 0.22 | 0.55 | 0.22 | 0.46 | 0.22 | 0.46 | |
Ridge regression models for treatment variables, generalized linear models for chronic conditions. Separate models for each cognitive outcome variable. Chemotherapy and radiation in the same models, chronic conditions in separate models. Non-standardized estimates. Cognitive measures in z-scores. Chemotherapy per mg/m2. Radiation as compared to no radiation. All models adjusted for sex, race/ethnicity and time since diagnosis. Bold type indicates significant models.